The goal of this clinical trial is to learn if platelet rich plasma works to treat early stage trigger finger in adults. It will also learn about the safety platelet rich plasma. The main questions it aims to answer are:
Does platelet rich plasma lower the pain associated with trigger finger of participants? Does it improve the hand grip strength and Q DASH score of participants? Researchers will compare platelet rich plasma to Depo-Medrol steroid (a known standard of care for early stage trigger finger) to see if platelet rich plasma works to treat early trigger finger.
Participants will:
Take platelet rich plasma or a depo-medrol steroid intralesional injection at recruitment into the intervention Visit the clinic once every 4 weeks for checkups and parameter measurements. Investigator will will keep a record of participants progress in symptom remission
Patients who are 18year and above with mild or moderate trigger finger, who are willing to have intra-lesional administration of blood product.
Previous steroid injection
Previous Surgery to that finger
Thrombocytopenic patients
Hand and finger contracture
Single group
Platelet rich plasma
Biological/VaccineFreshly prepared autologus platelet rich plasma
Pfizer Depo-medrol
DrugMethylprednisolone acetate 20mg/ml injection
symptom resolution post injection
reduction of pain using VAS and absence snapping of finger
Hand grip strength
measured grip using hand dynamomter
Q- DASH score
11-item self reported disability questionnaire that consider upper extremity as one functional unit
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
